A discussion with Dr. Anne Rowzee of the Center for Drug Evaluation and Research,
US FDA about patient input into the design of studies of medicines for multiple sclerosis.
–Therapeutic Innovation & Regulatory Science Podcast Series – November 2013
A discussion with Dr. Anne Rowzee of the Center for Drug Evaluation and Research,
US FDA about patient input into the design of studies of medicines for multiple sclerosis.
–Therapeutic Innovation & Regulatory Science Podcast Series – November 2013
